Natural Alternatives International Inc
NAII- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0000787253
No open-market purchases or sales by Natural Alternatives International Inc insiders were filed in the last 90 days; 23 institutions reported holding it in 13F filings for Q2 2026, worth $5.44M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Natural Alternatives International Inc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Natural Alternatives International Inc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Ledoux Mark A | CEO/Chairman | 176,737 | Mar 10, 2026 | 7 |
| Wolf Kenneth | President, COO, & Sec. | 141,831 | Mar 10, 2026 | 1 |
| Dunn Alan G | Director | 99,211 | Mar 10, 2026 | 1 |
| Ramanathan Guru | Director | 38,000 | Mar 10, 2026 | 1 |
| Fortin Michael E | Chief Financial Officer | 58,554 | Mar 10, 2026 | 1 |
| Matherly Laura Kay | Director | 42,000 | Mar 10, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 6, 2026 (view filing) | Mar 4-6 | 2 days | Ledoux Mark ACEO/Chairman | PPurchase | +1.25K | $2.78 | +$3.47K | +0.8%160.2K after | 3 lots |
| Mar 3, 2026 (view filing) | Feb 27-Mar 2 | 4 days | Ledoux Mark ACEO/Chairman | PPurchase | +1.00K | $2.82 | +$2.82K | +0.6%159.0K after | 2 lots |
| Feb 27, 2026 (view filing) | Feb 25-27 | 2 days | Ledoux Mark ACEO/Chairman | PPurchase | +1.25K | $2.82 | +$3.53K | +0.8%158.0K after | 3 lots |
| Feb 24, 2026 (view filing) | Feb 20-24 | 4 days | Ledoux Mark ACEO/Chairman | PPurchase | +2.00K | $2.70 | +$5.40K | +1.3%157.0K after | 3 lots |
| Feb 20, 2026 (view filing) | Feb 17-19 | 3 daysLate | Ledoux Mark ACEO/Chairman | PPurchase | +4.50K | $2.58 | +$11.6K | +3.0%154.7K after | 3 lots |
| Sep 1, 2021 (view filing) | Aug 30-Sep 1 | 2 days | Ledoux Mark ACEO/Chairman | SSale | −5.00K | $15.95 | −$79.8K | −3.1%158.7K after | 2 lots |
| Sep 1, 2021 (view filing) | Aug 30-Sep 1 | 2 days | Ledoux Mark ACEO/Chairman | SSale | −5.00K | $15.93 | −$79.7K | −1.0%481.9K after | 2 lots |
| Aug 4, 2021 (view filing) | Aug 2-3 | 2 days | Ledoux Mark ACEO/Chairman | SSale | −10.0K | $17.40 | −$174.0K | −5.8%163.7K after | 2 lots |
| Aug 4, 2021 (view filing) | Aug 2-3 | 2 days | Ledoux Mark ACEO/Chairman | SSale | −10.0K | $17.40 | −$174.0K | −2.0%486.9K after | 2 lots |
| Jul 14, 2021 (view filing) | Jul 12-14 | 2 days | Ledoux Mark ACEO/Chairman | SSale | −10.0K | $17.47 | −$174.7K | −38.2%16.2K after | 2 lots |
| Jul 14, 2021 (view filing) | Jul 12-14 | 2 days | Ledoux Mark ACEO/Chairman | SSale | −10.0K | $17.45 | −$174.5K | −2.0%500.9K after | 2 lots |
| Jul 2, 2021 (view filing) | Jun 30-Jul 2 | 2 days | Ledoux Mark ACEO/Chairman | SSale | −8.00K | $16.49 | −$131.9K | −23.4%26.2K after | 2 lots |
| Jul 2, 2021 (view filing) | Jun 30-Jul 2 | 2 days | Ledoux Mark ACEO/Chairman | SSale | −8.10K | $16.55 | −$133.9K | −1.6%510.9K after | 2 lots |